- Home
- A-Z Publications
- Current Drug Targets
- Previous Issues
- Volume 14, Issue 11, 2013
Current Drug Targets - Volume 14, Issue 11, 2013
Volume 14, Issue 11, 2013
-
-
Astrocyte-Neuron Interaction at Tripartite Synapses
Authors: Alberto Perez-Alvarez and Alfonso AraqueAstrocytes, classically considered as supportive cells for neurons without a direct role in brain information processing, are emerging as relevant elements in brain physiology through their ability to regulate neuronal activity and synaptic transmission and plasticity. In relation to the key role of astrocyte-neuron interactions in synaptic physiology, accumulating evidence suggests that dysfunctions of neuron-astrocyte signaling m Read More
-
-
-
Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Authors: Grazyna Rajkowska and Craig A. StockmeierThe present paper reviews astrocyte pathology in major depressive disorder (MDD) and proposes that reductions in astrocytes and related markers are key features in the pathology of MDD. Astrocytes are the most numerous and versatile of all types of glial cells. They are crucial to the neuronal microenvironment by regulating glucose metabolism, neurotransmitter uptake (particularly for glutamate), synaptic development and m Read More
-
-
-
Serum S100B Represents a New Biomarker for Mood Disorders
Authors: Matthias L. Schroeter, Julia Sacher, Johann Steiner, Peter Schoenknecht and Karsten MuellerRecently, mood disorders have been discussed to be characterized by glial pathology. The protein S100B, a growth and differentiation factor, is located in, and may actively be released by astro- and oligodendrocytes. This protein is easily assessed in human serum and provides a useful parameter for glial activation or injury. Here, we review studies investigating the glial marker S100B in serum of patients with mood diso Read More
-
-
-
Altered Glial Plasticity in Animal Models for Mood Disorders
Authors: Boldizsar Czeh, Eberhard Fuchs and Gabriele FluggeNumerous clinical evidences support the notion that glial changes in fronto-limbic brain areas could contribute to the pathophysiology of mood disorders. Glial alterations have been reported not only in patients, but also in various kinds of animal models for depression. Molecular and cellular data suggest that all the major classes of glial cells are affected in these conditions, including astrocytes, oligodendrocytes, NG2-positive Read More
-
-
-
Acute and Chronic Stress-Induced Disturbances of Microglial Plasticity, Phenotype and Function
Authors: Frederick Rohan Walker, Michael Nilsson and Kimberley JonesTraditionally, microglia have been considered to act as macrophages of the central nervous system. While this concept still remains true it is also becoming increasingly apparent that microglia are involved in a host of nonimmunological activities, such as monitoring synaptic function and maintaining synaptic integrity. It has also become apparent that microglia are exquisitely sensitive to perturbation by environmental chal Read More
-
-
-
The Monoaminergic Tripartite Synapse: A Putative Target for Currently Available Antidepressant Drugs
Authors: Gael Quesseveur, Alain M. Gardier and Bruno P. GuiardAntidepressant drugs such as the serotonin (5-HT)/norepinephrine (NE) and dopamine (DA) reuptake inhibitors activate monoaminergic neurotransmission in various brain regions, such as the amygdala, the frontal cortex or the hippocampus. Although this property is well established, the post-synaptic mechanisms by which these pharmacological agents exert therapeutic activity in major depressive disorders (MDD) is Read More
-
-
-
Astrocytes and Gliotransmitters: New Players in the Treatment of Major Depression?
Authors: Adeline Etievant, Laura Lambas-Senas, Helene Scarna, Guillaume Lucas and Nasser HaddjeriWith a lifetime prevalence of more than 16% worldwide, major depressive disorder is one of the most common psychiatric disorders. Only one third of patients experience a complete therapeutic improvement with the use of current antidepressant drugs, with a therapeutic effect appearing only after several weeks of treatment. Hence, a better understanding of the mechanisms of action of current antidepressant treatments is n Read More
-
-
-
Regulation of Neurotrophic Factors and Energy Metabolism by Antidepressants in Astrocytes
Authors: Jean-Luc Martin, Pierre J. Magistretti and Igor AllamanThere is growing evidence that astrocytes are involved in the neuropathology of major depression. In particular, decreases in glial cell density observed in the cerebral cortex of individuals with major depressive disorder are accompanied by a reduction of several astrocytic markers suggesting that astrocyte dysfunction may contribute to the pathophysiology of major depression. In rodents, glial loss in the prefrontal Read More
-
-
-
Glia: An Important Target for Anti-Inflammatory and Antidepressant Activity
Authors: Sadayuki Hashioka, Tsuyoshi Miyaoka, Rei Wake, Motohide Furuya and Jun HoriguchiActivated glial cells are capable of generating various inflammatory mediators, including cytokines, nitric oxide and reactive oxygen species. These potentially neurotoxic molecules have been suggested to play a role in the etiology and development of depression. Accumulating evidence indicates that antidepressants have inhibitory effects on inflammatory activation of glial cells and confer neuroprotection under neuropa Read More
-
-
-
Talking to the Synapse: How Antidepressants Can Target Glial Cells to Reshape Brain Circuits
Authors: Barbara Di Benedetto, Rainer Rupprecht and Boldizsar CzehFunctional alterations in synaptic contacts in specific brain areas are a hallmark of major depressive disorder (MDD). Antidepressant treatments not only readjust the aberrant concentrations of neurotransmitters in the synaptic clefts, but have the capacity to reshape neuronal circuits by affecting synaptogenesis and synaptic stabilization in specific regions of the brain. Nevertheless, the underlying molecular mechanisms are still un Read More
-
-
-
Lentiviral Vectors: A Powerful Tool to Target Astrocytes In Vivo
Authors: Delzor Aurelie, Escartin Carole and Deglon NicoleThe morphological and functional diversity of astrocytes, and their essential contribution in physiological and pathological conditions, are starting to emerge. However, experimental systems to investigate neuron-glia interactions and develop innovative approaches for the treatment of central nervous system (CNS) disorders are still very limited. Fluorescent reporter genes have been used to visualize populations of astrocytes a Read More
-
-
-
Molecular Mechanisms and Treatment of Radiation-Induced Lung Fibrosis
Authors: Nian-Hua Ding, Jian Jian Li and Lun-Quan SunRadiation-induced lung fibrosis (RILF) is a severe side effect of radiotherapy in lung cancer patients that presents as a progressive pulmonary injury combined with chronic inflammation and exaggerated organ repair. RILF is a major barrier to improving the cure rate and well-being of lung cancer patients because it limits the radiation dose that is required to effectively kill tumor cells and diminishes normal lung function. Although t Read More
-
-
-
Biomarkers for Early Detection of Non-Alcoholic Steatohepatitis: Implications for Drug Development and Clinical Trials
By Yusuf YilmazThe term non-alcoholic fatty liver disease (NAFLD) comprises at least four pathological entities (definite nonalcoholic steatohepatitis [NASH], borderline “zone 3” pattern, borderline “zone 1” pattern, not steatohepatitis with steatosis) with distinct patterns of lipid storage, fibrosis, and hepatocyte injury. Recent pathophysiological advances hold promise to provide much needed surrogate non-invasive biomarkers to dete Read More
-
-
-
25-(OH)VitD3, as a Risk Indicator in Diagnosis of Adenocarcinoma
Authors: Liang-Liang Cai, Hui-Ming Ye, Xiao-Nan Lv, Yun-long Wu, Huan-Jing Zhang, Li-Mou Zheng and Chi-Meng TzengVitamin D (VitD) comes from sunlight exposure and food intake. Apart from regulating calcium homeostasis and bone function, its levels also associate with the presence of development of adenocarcinoma. VitD can interact with VitD receptor (VDR), which heterodimerizes with retinoic X receptor (RXR) and then induces transcription of proteins that function in cell proliferation, differentiation, apoptosis, and angiogenesis. Read More
-
Volumes & issues
-
Volume 26 (2025)
-
Volume 25 (2024)
-
Volume 24 (2023)
-
Volume 23 (2022)
-
Volume 22 (2021)
-
Volume 21 (2020)
-
Volume 20 (2019)
-
Volume 19 (2018)
-
Volume 18 (2017)
-
Volume 17 (2016)
-
Volume 16 (2015)
-
Volume 15 (2014)
-
Volume 14 (2013)
-
Volume 13 (2012)
-
Volume 12 (2011)
-
Volume 11 (2010)
-
Volume 10 (2009)
-
Volume 9 (2008)
-
Volume 8 (2007)
-
Volume 7 (2006)
-
Volume 6 (2005)
-
Volume 5 (2004)
-
Volume 4 (2003)
-
Volume 3 (2002)
-
Volume 2 (2001)
-
Volume 1 (2000)
Most Read This Month
Article
content/journals/cdt
Journal
10
5
false
en
